Living with obstructive or non-obstructive hypertrophic cardiomyopathy (HCM) can affect everyday life, your plans and the ...
Hypertrophic cardiomyopathy (HCM) is a condition that thickens some of the heart’s muscles, making it harder for the heart to pump blood. Hypertrophic cardiomyopathy (HCM) usually affects the ...
What is Hypertrophic Cardiomyopathy (HCM)? Hypertrophic cardiomyopathy (HCM) is a condition that affects the muscle layer of the heart in patients without any underlying heart problems or systemic ...
About Chengdu Origen and Vanotech Chengdu Origen is a clinical-stage gene therapy company focused on developing gene therapy for unmet medical needs and providing meaningful clinical benefits for ...
Topline results announced today show gains in KCCQ and peak oxygen consumption—the full dataset is coming soon.
The Southern Maryland Chronicle on MSN

New biomarkers could save lives in common heart condition

A new study is reshaping how doctors assess and treat hypertrophic cardiomyopathy (HCM), the most common cause of sudden ...
Diet plays a surprising role in managing oHCM symptoms. From hydration strategies to sodium balance, learn how to eat to ...
Hypertrophic cardiomyopathy (HCM) is often seen in patients as an autosomal dominant genetic heart disease with a variable clinical course. It is characterized by left ventricular hypertrophy, and ...
A small panel of circulating biomarkers may reliably distinguish hypertrophic cardiomyopathy (HCM) from similar conditions that cause left ventricular hypertrophy (LVH), researchers found. From ...
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced positive topline results from ACACIA-HCM (Assessment Comparing ...
Robert Blum and Fady Malik, M.D., Ph.D, have been with Cytokinetics since its inception nearly three decades ago. | ...
Hypertrophic cardiomyopathy is an underdiagnosed genetic disorder, resulting from mutations in sarcomeric proteins. It has a highly variable clinical presentation, with some individuals remaining ...